← All Posts
- min read Earnings & Filings

Nebius Q3: Revenue Up 571% to $980.8M, $325M Was One-Off, and the Stock Fell 16.8% (Nov 13, 2026)

Nebius Q3 revenue rose 571% to $980.8M, but $325M was non-recurring, ARR guidance was dropped and the stock fell 16.8% on Nov 12.

Nebius reported third-quarter results before the open on Thursday, Nov 12, and the stock still sold off hard. Revenue grew 571% year over year. The shares fell about 16.8% anyway, on 2.2x normal volume, per the OpticAlpha market movers pane. The gap between those two facts is the whole story, and it sits in the footnotes of the shareholder letter.

How big was the Nebius Q3 revenue number?

Nebius posted $980.8 million of Q3 revenue, up 571% from $146.1 million a year earlier. Adjusted EBITDA was $465.8 million, against a $5.2 million loss in Q3 2025. The net loss from continuing operations narrowed to $37.5 million from $119.6 million. Nine-month revenue reached $1.96 billion. On the headline line, this was a clean quarter.

Why did the stock fall on a 571% growth print?

Because the quality of the revenue changed the read. The shareholder letter says the company recognized approximately $325 million of non-recurring revenue under its asset-light model. That is about a third of the quarter. Strip it out and the run-rate story gets smaller, which matters for a stock valued on run-rate.

What happened to the annualized run-rate revenue target?

Nebius had guided to $7 to $9 billion of annualized run-rate revenue (ARR) by December. It now expects ARR to exceed $7 billion for the month of February, about two months later and at the bottom of the old range. The letter then adds that the company no longer sees ARR as the right measure of its business. From 2027 it will guide on revenue and pre-tax earnings instead.

A target that slips and then gets retired in the same letter is the kind of change tape traders price immediately.

Did full-year guidance change?

The range did not move, but the expected landing point did. Nebius still guides to $3.0 to $3.4 billion of 2026 revenue and now expects the low end. The adjusted EBITDA margin guide of roughly 40% is unchanged. The cause is timing: delivery dates at a number of colocation sites shifted into the first half of 2027, and the remaining tranches of Microsoft-contracted capacity in New Jersey now land in the second quarter of 2027.

How much is Nebius spending to build this?

Q3 capital expenditure was $7.30 billion, against $955.5 million a year earlier. For 2027 the company points to $40 to $45 billion of capex, with prepayments and financing against existing investment-grade contracts covering 75% to 85% of it. Customer prepayments are expected at $10 billion in 2026 and $17 to $20 billion in 2027. The bet is large, and it is funded mostly by customers who have already signed.

What does the sell-side still think?

Eleven analysts tracked on the OpticAlpha analyst scoreboard show a consensus rating of Buy and a median target of $312, about 142.5% above the price shown. Targets range from $185 to $410, a dispersion of 72%. The pane shows zero upward or downward revisions in the last 30 days, so analysts had not repriced when it was captured.

On options, the IV profile pane shows an IV rank of 28% and an IV percentile of 60.3%, with call open interest near 978,000 contracts against roughly 937,000 puts. That is not panic positioning.

What should traders watch next?

Three dates matter: the February ARR checkpoint, the first-half 2027 colocation deliveries, and the first guide framed in revenue and pre-tax earnings. The stock has moved a median 7.0% on its last nine earnings reports, per the terminal's implied-versus-past-moves pane. Thursday's drop was more than twice that.

Track live movers, analyst targets and options positioning at opticalpha.net/terminal. 14-day free trial, no credit card required.

See the data behind the analysis

17 live tabs across equities, crypto, forex, options and macro. Free for 14 days.

View pricing